サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413126

神経血管インターベンション機器市場：製品、プロセス、疾患病態、治療用途、最終用途別-2024-2030年の世界予測

Neurovascular Intervention Devices Market by Product, Process, Disease Pathology, Therapeutic Applications, Application, End-use - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
神経血管インターベンション機器市場：製品、プロセス、疾患病態、治療用途、最終用途別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経血管インターベンション機器市場規模は2023年に37億5,000万米ドルと推計され、2024年には39億5,000万米ドルに達し、CAGR 6.47%で2030年には58億3,000万米ドルに達すると予測されます。

神経血管インターベンション機器の世界市場

主な市場の統計
基準年[2023］ 37億5,000万米ドル
予測年[2024］ 39億5,000万米ドル
予測年 [2030] 58億3,000万米ドル
CAGR（%） 6.47%
神経血管インターベンション機器 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは神経血管インターベンション機器市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、神経血管インターベンション機器市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-神経血管インターベンション機器市場の市場規模および予測は？

2-神経血管インターベンション機器市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-神経血管インターベンション機器市場における技術動向と規制の枠組みは？

4-神経血管インターベンション機器市場における主要ベンダーの市場シェアは？

5-神経血管インターベンション機器市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 効果的な神経血管デバイスに対する需要の高まり
      • 新興市場全体でヘルスケアインフラを最新化し、拡大する政府の取り組み
      • 成熟経済における医療報酬の改善
    • 抑制要因
      • 神経血管インターベンション機器に関連する厳しい規制シナリオ
    • 機会
      • 神経血管治療の分野における研究数の増加
      • 低侵襲外科手術に対する脳神経外科医の意識の高まり
    • 課題
      • 熟練した脳外科医が不足している
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 神経血管インターベンション機器市場：製品別

  • バルーンシステム
  • 頸動脈ステント
  • カテーテル
  • 塞栓コイル
  • 塞栓防止装置
  • 分流器
  • ガイドワイヤー
  • 頭蓋内ステント
  • 嚢内装置
  • 神経血栓除去装置
  • ステントレトリーバー

第7章 神経血管インターベンション機器市場：プロセス別

  • 頸動脈内膜切除術
  • 脳血管造影
  • コイリング
  • 流れの迂回
  • 顕微手術クリッピング
  • 神経血栓除去術
  • ステント留置術

第8章 神経血管インターベンション機器市場疾患病理学別

  • 動静脈奇形と瘻孔
  • 頸動脈狭窄症
  • 大脳動脈瘤
  • 虚血性脳卒中

第9章 神経血管インターベンション機器市場治療用途別

  • 脳動脈瘤
  • 虚血性脳卒中
  • 狭窄

第10章 神経血管インターベンション機器市場：用途別

  • 動静脈奇形
  • 頭蓋内動脈瘤
  • 虚血性脳卒中

第11章 神経血管インターベンション機器市場：最終用途別

  • 外来手術センター
  • 病院

第12章 南北アメリカの神経血管インターベンション機器市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 アジア太平洋地域の神経血管インターベンション機器市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第14章 欧州・中東・アフリカの神経血管インターベンション機器市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第16章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Acandis GmbH
    • Boston Scientific Corporation
    • Evasc Medical Systems Corp.
    • Johnson & Johnson Services, Inc.
    • LivaNova PLC
    • Medikit Co., Ltd.
    • Medtronic PLC
    • Microport Scientific Corporation
    • Penumbra, Inc.
    • Phenox GmbH
    • Rapid Medical Ltd.
    • Stryker Corporation
    • Terumo Corporation
  • 主要な製品ポートフォリオ

第17章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
  • FIGURE 7. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 10. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 14. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 18. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 28. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 18. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 31. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 193. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 199. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 205. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 235. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 259. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 265. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 277. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 291. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 292. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 293. NEUROVASCULAR INTERVENTION DEVICES MARKET LICENSE & PRICING
目次
Product Code: MRR-ED54C46E8FB5

[180 Pages Report] The Neurovascular Intervention Devices Market size was estimated at USD 3.75 billion in 2023 and expected to reach USD 3.95 billion in 2024, at a CAGR 6.47% to reach USD 5.83 billion by 2030.

Global Neurovascular Intervention Devices Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.75 billion
Estimated Year [2024] USD 3.95 billion
Forecast Year [2030] USD 5.83 billion
CAGR (%) 6.47%
Neurovascular Intervention Devices Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neurovascular Intervention Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neurovascular Intervention Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Boston Scientific Corporation, Evasc Medical Systems Corp., Johnson & Johnson Services, Inc., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Microport Scientific Corporation, Penumbra, Inc., Phenox GmbH, Rapid Medical Ltd., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Balloon Systems
    • Carotid Stents
    • Catheters
    • Embolic Coils
    • Embolic Protection Devices
    • Flow Diverters
    • Guidewires
    • Intracranial Stents
    • Intrasaccular Devices
    • Neurothrombectomy Devices
    • Stent Retrievers
  • Process
    • Carotid Endarterectomy
    • Cerebral Angiography
    • Coiling
    • Flow Diversion
    • Microsurgical Clipping
    • Neurothrombectomy
    • Stenting
  • Disease Pathology
    • Arteriovenous Malformations & Fistulas
    • Carotid Artery Stenosis
    • Cerebral Aneuryms
    • Ischemic Strokes
  • Therapeutic Applications
    • Brain Aneurysm
    • Ischemic Strokes
    • Stenosis
  • Application
    • Arteriovenous Malformation
    • Intracranial Aneurysm
    • Ischemic Stroke
  • End-use
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Neurovascular Intervention Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neurovascular Intervention Devices Market?

3. What are the technology trends and regulatory frameworks in the Neurovascular Intervention Devices Market?

4. What is the market share of the leading vendors in the Neurovascular Intervention Devices Market?

5. Which modes and strategic moves are suitable for entering the Neurovascular Intervention Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neurovascular Intervention Devices Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for effective neurovascular devices
      • 5.1.1.2. Government initiatives to modernize and expand healthcare infrastructure across emerging markets
      • 5.1.1.3. Improvements in medical reimbursement in mature economies
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory scenario associated with neurovascular intervention devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising number of researches in the field of neurovascular therapies
      • 5.1.3.2. Growing awareness among neurosurgeons about minimally invasive surgical procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled neurosurgeons
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Neurovascular Intervention Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Balloon Systems
  • 6.3. Carotid Stents
  • 6.4. Catheters
  • 6.5. Embolic Coils
  • 6.6. Embolic Protection Devices
  • 6.7. Flow Diverters
  • 6.8. Guidewires
  • 6.9. Intracranial Stents
  • 6.10. Intrasaccular Devices
  • 6.11. Neurothrombectomy Devices
  • 6.12. Stent Retrievers

7. Neurovascular Intervention Devices Market, by Process

  • 7.1. Introduction
  • 7.2. Carotid Endarterectomy
  • 7.3. Cerebral Angiography
  • 7.4. Coiling
  • 7.5. Flow Diversion
  • 7.6. Microsurgical Clipping
  • 7.7. Neurothrombectomy
  • 7.8. Stenting

8. Neurovascular Intervention Devices Market, by Disease Pathology

  • 8.1. Introduction
  • 8.2. Arteriovenous Malformations & Fistulas
  • 8.3. Carotid Artery Stenosis
  • 8.4. Cerebral Aneuryms
  • 8.5. Ischemic Strokes

9. Neurovascular Intervention Devices Market, by Therapeutic Applications

  • 9.1. Introduction
  • 9.2. Brain Aneurysm
  • 9.3. Ischemic Strokes
  • 9.4. Stenosis

10. Neurovascular Intervention Devices Market, by Application

  • 10.1. Introduction
  • 10.2. Arteriovenous Malformation
  • 10.3. Intracranial Aneurysm
  • 10.4. Ischemic Stroke

11. Neurovascular Intervention Devices Market, by End-use

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Hospitals

12. Americas Neurovascular Intervention Devices Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Neurovascular Intervention Devices Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Neurovascular Intervention Devices Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. FPNV Positioning Matrix
  • 15.2. Market Share Analysis, By Key Player
  • 15.3. Competitive Scenario Analysis, By Key Player

16. Competitive Portfolio

  • 16.1. Key Company Profiles
    • 16.1.1. Abbott Laboratories
    • 16.1.2. Acandis GmbH
    • 16.1.3. Boston Scientific Corporation
    • 16.1.4. Evasc Medical Systems Corp.
    • 16.1.5. Johnson & Johnson Services, Inc.
    • 16.1.6. LivaNova PLC
    • 16.1.7. Medikit Co., Ltd.
    • 16.1.8. Medtronic PLC
    • 16.1.9. Microport Scientific Corporation
    • 16.1.10. Penumbra, Inc.
    • 16.1.11. Phenox GmbH
    • 16.1.12. Rapid Medical Ltd.
    • 16.1.13. Stryker Corporation
    • 16.1.14. Terumo Corporation
  • 16.2. Key Product Portfolio

17. Appendix

  • 17.1. Discussion Guide
  • 17.2. License & Pricing